2017 May 31
First clinical trial of new targeted molecular therapy in U.S. takes aim at incurable prostate cancer
Weill Cornell clinicians have begun the first clinical trial in the United States that uses a radiopharmaceutical to treat men with progressive prostate cancer that has spread beyond the prostate and is no longer responding to hormonal therapy. Read more




















